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Aberrant expression of miR-335 has been frequently
reported in cancer studies, suggesting that there is a close
correlation between miR-335 and cancer during its
development, progression, metastasis and prognosis. The
expression of miR-335 in gastric cancer and its effects are
not known. Relative expression of miR-335 in 4 gastric
cancer cell lines and in 70 gastric cancer tissues was
conﬁrmed by real-time quantitative reverse transcriptase-
PCR compared with controls. Transwell cell migration
and Matrigel invasion assay in vitro and metastasis
formation assay in vivo were used to examine the effects
of miR-335 expression on gastric cancer cell invasion and
metastasis. The effect of miR-335 expression on gastric
cancer cell proliferation was estimated by the 3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
assay. Luciferase reporter assay and western blot were
used to examine the potential target genes and related
pathways. Gene silencing with small-interfering RNA was
used to examine the effects of target genes on gastric
cancer cell invasion. miR-335 was dramatically down-
regulated in gastric cancer cell lines than in the normal
gastric cell line GES-1. Low expression of miR-335 was
signiﬁcantly associated with lymph-node metastasis, poor
pT stage, poor pN stage and invasion of lymphatic vessels.
Overexpression of miR-335 suppressed gastric cancer cell
invasion and metastasis in vitro and in vivo, but has no
signiﬁcant effects on cell proliferation. Furthermore, miR-
335 might suppress gastric cancer invasion and metastasis
by targeting Bcl-w and speciﬁcity protein 1 (SP1). Taken
together, our results provide evidence that miR-335 might
function as a metastasis suppressor in gastric cancer by
targeting SP1 directly and indirectly through the Bcl-
w-induced phosphoinositide 3-kinase-Akt-Sp1 pathway.
miR-335 showing altered expression at different stages of
gastric cancer could be a target for gastric cancer
therapies and could be further developed as a potential
prognostic factor.
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Introduction
Until the mid-1990s, gastric cancer was the most
common cause of cancer death worldwide (Bertuccio
et al., 2009). Although the incidence of gastric cancer
has been declining in the past several decades, it remains
the second most common cause of cancer death (Parkin
et al., 2005). The molecular mechanisms of gastric
cancer remain to be further elucidated.
Recently, the classical categories of oncogenes and
tumor-suppressor genes have been expanded to include
a new family of RNAs known as microRNAs (miR-
NAs), which may regulate a vast number of protein-
coding genes, including tumor-related genes (Liu et al.,
2008; Wu et al., 2010). miRNAs are a large family of
highly conserved small non-coding RNAs that can have
important regulatory roles in animals and plants. They
trigger translational repression and/or mRNA degrada-
tion mostly through complementary binding to the
30-untranslated (30-UTR) regions of target mRNAs
(Calin et al., 2002; Bartel, 2004; Wu et al., 2006). More
than half of human miRNA genes are in cancer-
associated genomic regions or in fragile sites (Calin
et al., 2004). Evidence has shown that miRNAs repress
the expression of important cancer-related genes and
that downregulation or upregulation of miRNAs is
correlated with various human cancers, indicating that
miRNAs can function as tumor suppressors or onco-
genes (Costinean et al., 2006; Volinia et al., 2006;
Bommer et al., 2007; Gironella et al., 2007; Chen et al.,
2010). Recently, the aberrant expression of miRNA has
been frequently reported in gastric cancer, suggesting
that there is a close correlation between miRNAs and
the development, progression, metastasis and prognosis
of gastric cancer (Petrocca et al., 2008; Du et al., 2009;
Kim et al., 2009; Chiang et al., 2010; Wada et al., 2010;
Wu et al., 2010; Song et al., 2011).
The low expression of miR-335 has a close correlation
with cancer development (Marcucci et al., 2008;
Sorrentino et al., 2008; Soon et al., 2009; Wang et al.,
2010). In addition, miR-335 has been identiﬁed as a
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expression of miR-335 is lost in the majority of primary
breast tumors from patients who relapse, and the loss of
miR-335 expression is associated with poor distal
metastasis-free survival. It regulates a set of genes,
which are SOX4, PTPRN2, MERTK and possibly TNC,
the collective expression of which in a large cohort of
human tumors is associated with the risk of distal
metastasis (Tavazoie et al., 2008).
In our study, a signiﬁcant low expression of miR-335
was found in gastric cancer cell lines. The relative
expression of miR-335 in gastric cancer tissues showed
that low expression of miR-335 is associated with
lymph-node metastasis, poor pT stage, poor pN stage
and invasion into lymphatic vessels. Transwell cell
migration and Matrigel invasion assay in vitro and
metastasis formation assay in vivo demonstrated that
overexpression of miR-335 has the effect of suppressing
gastric cancer cell invasion and metastasis. Further-
more, we used a luciferase reporter assay and western
blot to conﬁrm that miR-335 may function as a
metastatic suppressor in gastric cancer by targeting
speciﬁcity protein 1 (SP1) directly and indirectly
through a Bcl-w-induced signaling pathway that sequen-
tially involves phosphoinositide 3-kinase (PI3K), Akt
and Sp1.
Results
miR-335 is downregulated in human gastric cancer cell
lines
We detected the expression of miR-335 in ﬁve human
gastric cell lines (namely SGC-7901, MGC-803, BGC-
823, AGS and GES-1) by real-time quantitative reverse
transcriptase-PCR (RT–PCR) and found that miR-335
was downregulated in gastric cancer cell lines SGC-
7901, MGC-803, BGC-823 and AGS compared with a
normal gastric epithelial cell line GES-1 (MGC-803,
0.07±0.02-fold (Po0.01); SGC-7901, 0.1±0.006-fold
(Po0.01); BGC-823, 0.5±0.02-fold (Po0.01); AGS,
0.9±0.08-fold (P¼0.3); Figure 1a).
Relative expression of miR-335 in gastric cancer tissues
and its correlation with clinicopathological features
To determine whether miR-335 expression is associated
with gastric cancer, we examined miR-335 expression in
a large cohort consisting of 70 primary gastric cancer
tissues relative to their pair-matched adjacent non-
tumor tissues using real-time quantitative RT–PCR
(qRT–PCR). No statistical signiﬁcance was found with
miR-335 expression between gastric cancer tissues
and their pair-matched adjacent non-tumor tissues
Figure 1 The expression of miR-335 in tissues and cell lines. (a) Relative expression of miR-335 in four gastric cancer cell lines
(MGC-803, SGC-7901, BGC-823 and AGS). Quantiﬁcation of miR-335 was measured by qRT–PCR. Data are presented in gastric
cancer cell lines relative to GES-1 (which is a normal gastric epithelial cell line that was chosen as a control). Results represent the
means of the values. Bars indicate s.d. ** Refers to statistical signiﬁcance between groups (Po0.01). (b) There is no statistical
signiﬁcance with miR-335 expression between gastric cancer tissues and their pair-matched adjacent non-tumor tissues (P¼0.7). miR-
335 was normalized by U6RNA. DCT¼CT miR-335 CT U6RNA. Results represent the means of the values. Bars indicate s.d.
(c) Relative expression of miR-335 in 70 patients with gastric cancer. Quantiﬁcation of miRNAs was measured by qRT–PCR.
Data that were transformed to log2 values in gastric cancer tissues relative to their matched non-tumor adjacent tissues were divided
into two groups of metastasis free and metastasis positive. The non-parametric test revealed that the low expression of miR-335 was
signiﬁcantly associated with lymph-node metastasis (Po0.001). (d) The non-parametric test demonstrated that patients with better pT
stage had signiﬁcantly higher miR-335 expression than did those with poor pT stage (Po0.05). Quantiﬁcation of miRNAs was
measured by qRT–PCR. Results represent the median of the values, which are the relative expressions of miR-335 associated with
the pT stage.
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Oncogene(Figure 1b). The non-parametric test revealed that the
low expression of miR-335 was signiﬁcantly associated
with lymph-node metastasis (Po0.001), poor pT stage
(Po0.05), poor pN stage (Po0.05) and invasion into
lymphatic vessels (Po0.05; Table 1). The data showed
that the high expression of miR-335 was clearly found in
82.4% of the 17 cases that were found to be metastasis
free. On the contrary, of the 53 cases that were found to
have metastasis lymph nodes, only 32.1% showed high
expression of miR-335 (Figure 1c). The non-parametric
test demonstrated that patients with a better pT stage
had signiﬁcantly higher miR-335 expression (4.0-fold
with T1 and 3.5-fold with T2) than did those with a poor
pT stage (1.0-fold with T3 and 0.6-fold with T4;
Po0.05; Figure 1d). Similarly, patients with a better
pN stage had signiﬁcantly higher miR-335 expression
(2.1-fold with N1þN2) than did those with a poor pN
stage (0.6-fold with N3þN4; Po0.05). Moreover,
patients with a low expression of miR-335 tended to
have metastasis invasion into lymphatic vessels.
miR-335 suppresses gastric cancer invasion in vitro
To explore the role of miR-335 in gastric cancer, BGC-
823 and SGC-7901 cell lines were transfected with hsa-
miR-335 mimics or stable negative control (NC), and
AGS cells were transfected with anti-miR-335 or anti-
NC. Transfection efﬁciency was perfect (Supplementary
Figures S1a–c). We estimated the effects of miR-335 on
the invasion of cells derived from gastric cancer using a
transwell cell migration and Matrigel invasion assay.
The data demonstrated that overexpression of miR-335
obviously inhibited the invasion and metastasis of BGC-
823 and SGC-7901 cell lines, and that invasion of AGS
cells transfected with anti-miR-335 was increased
compared with that of cells transfected with anti-NC
and blank controls. The numbers of miR-335-trans-
fected BGC-823 cells (19±5, Po0.01) passing through
the Matrigel were signiﬁcantly lower than those of NC-
transfected BGC-823 cells (36±6) and parental BGC-
823 cells (38±7) (Figures 2a and d). A similar result was
found with SGC-7901 cells; the numbers of miR-335-
transfected SGC-7901 cells (16±5, Po0.01) passing
through the Matrigel were signiﬁcantly lower than those
of NC-transfected SGC-7901 cells (35±9) and parental
SGC-7901 cells (37±9) (Figures 2b and e). On the
contrary, the numbers of anti-miR-335-transfected
AGS cells (57±17, Po0.01) passing through the
Matrigel were signiﬁcantly higher than those of anti-
NC-transfected AGS cells (38±9) and parental AGS
cells (37±11) (Figures 2c and f). There were no
signiﬁcant differences between all NC-transfected
and parental cells (PBGC 823¼0.2, PSGC 7901¼0.2,
PAGS¼0.9; Figure 2).
miR-335 suppresses gastric cancer metastasis in vivo
We used a metastasis formation assay in nude mice
in vivo approach. In all, 5 10
5 viable parental SGC-
7901 cells or SGC-7901 cells transfected with hsa-miR-
335 mimics or stable NC were resuspended in 0.1ml
phosphate-buffered saline and injected into the lateral
tail vein. Five weeks after injection, we killed the mice
and dissected the lungs for microscopic histology. The
numbers of lung metastases in mice that were injected
with miR-335-transfected SGC-7901 cells were signiﬁ-
cantly lower than those in mice injected with NC-
transfected SGC-7901 cells (Po0.01; Figure 3), demon-
strating that miR-335 overexpression obviously inhib-
ited the metastasis effect of the SGC-7901 cell line
in vivo.
miR-335 has no signiﬁcant effects on cell proliferation of
gastric cancer
An MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenylte-
trazolium bromide) assay was used to estimate
the proliferation ability of miR-335-transfected, NC-
transfected and parental SGC-7901 cells. The result
Table 1 Comparison of expression levels of miR-335 with clinico-
pathological features in patients with gastric cancer
N miR-335
a P-value
Sex
Male 57 0.8 (0.2–3.3) 0.5
Female 13 1.1 (0.5–4.4)
Age (years)
p55 27 1.1 (0.5–6.2) 0.1
455 43 0.8 (0.2–2.6)
Tumor size (cm)
p3.5 14 2.7 (0.3–10.0) 0.1
43.5 56 0.8 (0.3–2.3)
Macroscopic type
Eraly stage 1 4.0 0.6
Borrmann IþII 6 0.8 (0.2–2.5)
Borrmann IIIþIV 63 0.8 (0.3–3.9)
Histological grade
Well 14 0.8 (0.4–7.2) 0.7
Poor 56 0.9 (0.2–2.9)
Lauren’s grade
Intestinal 22 0.8 (0.3–4.6) 0.9
Diffuse 48 0.9 (0.3–2.7)
pT stage
T1 1 4.0 0.03*
T2 12 3.5 (0.7–10.6)
T3 21 1.0 (0.4–3.3)
T4 36 0.6 (0.2–2.0)
pN stage
N0þN1 23 2.1 (1.0–8.4) 0.01*
N2þN3 47 0.6 (0.2–2.2)
Metastasis lymph node
Negative 17 2.6 (1.2–10.2) 0.000*
Positive 53 0.6 (0.2–2.0)
Invasion into lymphatic vessels
Negative 54 1.1 (0.3–6.0) 0.02*
Positive 16 0.5 (0.2–0.9)
*Indicated statistical signiﬁcance (Po0.05).
aMedian of relative expression, with 25th–75th percentile in
parenthesis.
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Oncogeneshowed that overexpression of miR-335 in SGC-7901
cells has no signiﬁcant effects on cell proliferation
(Supplementary Figure S2).
miR-335 suppresses gastric cancer invasion and
metastasis by targeting Bcl-w and SP1
For miRNA target gene prediction, we used TargetScan
Release 5.1 online software (http://www.targetscan.org/,
Whitehead Institute for Biomedical Research, Cambridge,
MA, USA). Among a total of 146 genes that were
potentially targeted by miR-335, we found that SP1 and
Bcl-w may contribute to the metastasis of gastric cancer.
To conﬁrm that SP1 and Bcl-w are direct targets of
miR-335, we constructed luciferase reporter pGL3-SP1-
30-UTR and pGL3-Bcl-w-30-UTR. Scrambled target
sites (pGL3-SP1-MUT and pGL3-Bcl-w-MUT) were
also constructed as controls for sequence speciﬁcity. All
the reporters were transfected in SGC-7901 cells. The
luciferase activity of pGL3-SP1-30-UTR and pGL3-
Bcl-w-30-UTR reporters was signiﬁcantly suppressed in
miR-335-transfected SGC-7901 cells than in NC-trans-
Figure 2 miR-335 inhibits cell invasion in vitro.( a) Representative photomicrographs of transwell results for BGC-823 cells were
taken under  100 original magniﬁcation. (b) Representative photomicrographs of transwell results for SGC-7901 cells were taken
under  100 original magniﬁcation. (c) Representative photomicrographs of transwell results for AGS cells were taken under  100
original magniﬁcation. (d) The numbers of miR-335-transfected BGC-823 cells passing through the Matrigel were signiﬁcantly lower
than those of NC-transfected and parental BGC-823 cells. The number of cells was counted in 16 independent symmetrical visual ﬁelds
under the microscope ( 400 original magniﬁcation) from three independent experiments. Results represent the means of the values
from three independent experiments. Bars indicate s.d. * Refers to statistical signiﬁcance between groups (Po0.05). (e) The numbers of
miR-335-transfected SGC-7901 cells passing through the Matrigel were signiﬁcantly lower than those of NC-transfected and parental
SGC-7901 cells. The number of cells was counted in 16 independent symmetrical visual ﬁelds under the microscope ( 200 original
magniﬁcation) from three independent experiments. Results represent the means of the values from three independent experiments.
Bars indicate s.d. * Refers to statistical signiﬁcance between groups (Po0.05). (f) The numbers of anti-miR-335-transfected AGS cells
passing through the Matrigel were signiﬁcantly higher than those of NC-transfected and parental AGS cells. The number of cells was
counted in 16 independent symmetrical visual ﬁelds under the microscope ( 200 original magniﬁcation) from three independent
experiments. Results represent the means of the values from three independent experiments. Bars indicate s.d. * Refers to statistical
signiﬁcance between groups (Po0.05).
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Oncogenefected SGC-7901 cells normalized to a control vector
containing Renilla luciferase, pRL-TK. On the contrary,
there were no signiﬁcantly differences of the relative
luciferase activity of pGL3-SP1-MUT and pGL3-Bcl-
w-MUT reporters in miR-335-transfected SGC-7901
cells compared with NC-transfected SGC-7901 cells
(Figures 4a and b). These results showed that SP1 and
Bcl-w are negatively regulated directly by miR-335 in
gastric cancer cells.
In support of these results, we examined the SP1 and
Bcl-w proteins and mRNA levels in miR-335-trans-
fected, anti-miR-335-transfected, their respective NC
and parental SGC-7901 cells by western blot and real-
time qRT–PCR (transfection efﬁciency of anti-miR-335
was shown in Supplementary Figure S1d). We observed
a clear reduction in the level of the endogenous SP1 and
Bcl-w proteins in miR-335-transfected SGC-7901 cells
than in NC-transfected and parental SGC-7901 cells
normalized to an endogenous reference b-actin protein
(Figure 4e). Overexpression of SP1 and Bcl-w proteins
was also found in anti-miR-335-transfected SGC-7901
cells compared with anti-NC-transfected and parental
SGC-7901 cells (Figure 4f). These results demonstrated
that miR-335 may target SP1 and Bcl-w in gastric
cancer. Despite the effect of miR-335 on SP1 and Bcl-w
protein levels, no effect on SP1 and Bcl-w mRNA levels
was detected (Figures 4c and d).
Knockdown of the SP1 and Bcl-w genes suppresses gastric
cancer invasion in vitro
The above results showed that miR-335 suppresses
gastric cancer invasion and metastasis in vitro and
in vivo. Moreover, SP1 and Bcl-w are potential targets of
miR-335. Do SP1 and Bcl-w genes have any effects on
gastric cancer cell invasion? To this end, the expressions
of the SP1 and Bcl-w genes of SGC-7901 cells were
knocked down by transfection with small-interfering
RNA (siRNA) (Supplementary Figures S3a–c). A
transwell cell migration and Matrigel invasion assay
showed that knockdown of SP1 and Bcl-w gene
expressions signiﬁcantly inhibited the invasion and
metastasis of SGC-7901 cells in vitro (Supplementary
Figures S3d and e).
Discussion
The low expression of miR-335, which has a close
correlation with the development, progression, metas-
tasis and prognosis of cancer, has been frequently
reported. With a RT–PCR assay, miR-335 has been
found to be downregulated in breast cancer tissues and
sera (Wang et al., 2010). Similarly, the low expression of
miR-335 was signiﬁcantly associated with adrenocorti-
cal carcinomas and acute myeloid leukemia (Marcucci
et al., 2008; Soon et al., 2009). Sorrentino et al. (2008)
revealed that there is a direct correlation between
development of ovarian cancer cell chemoresistance
and low expression of miR-335. In this study, we found
that miR-335 was dramatically downregulated in gastric
cancer cell lines, suggesting that the low expression of
miR-335 is signiﬁcantly associated with gastric cancer.
However, overexpression of miR-335 may also have an
important role in the development of several cancers,
including colonic cancer, pediatric acute leukemia and
multiple myeloma (Ronchetti et al., 2008; Zhang et al.,
2009; Wang et al., 2010). This distinction may be caused
by tissue speciﬁcity or ethnic diversity.
We also analyzed the relative expression of miR-335
in gastric cancer tissues and demonstrated that the low
expression of miR-335 was signiﬁcantly associated with
lymph-node metastasis, poor pT stage, poor pN stage
and invasion into lymphatic vessels. Lymph-node
metastasis, pT stage and pN stage are independent
prognosis factors associated with the overall survival
rates of gastric cancer patients, and lymphatic vessel
invasion is identiﬁed as an independent factor predicting
lymph-node metastasis. Gastric cancer patients with
lymph-node metastasis, poor pT stage, poor pN stage
and invasion into lymphatic vessels tend to have a low
survival rate (Xu et al., 2007; Sun et al., 2009, 2010;
Jiang et al., 2010). This suggests that the expression of
miR-335 may act as an independent prognosis factor
that is signiﬁcantly associated with overall survival rates
of gastric cancer patients. Further studies demonstrated
that overexpression of miR-335 has the effect of
suppressing gastric cancer cell invasion and metastasis.
These results are consistent with a report that showed
that the expression of miR-335 is lost in the majority of
primary breast tumors from patients who relapse, and
that the loss of the expression of miR-335 is associated
with poor distal metastasis-free survival (Tavazoie et al.,
Figure 3 miR-335 suppresses gastric cancer metastasis in vivo.
(a) Representative photographs for lung tissues. Cell aggregates,
which were observed by staining with dark nucleus, represent lung
metastases. (b) The data are shown graphically with the number of
lung metastases from each mouse. Results represent the means
of the values. Bars indicate s.d. * Refers to statistical signiﬁcance
between groups (Po0.05).
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Oncogene2008). Our ﬁndings suggest that miR-335 may function
as a metastasis suppressor in gastric cancer.
What is the molecular mechanism by which miR-335
acts as a metastasis suppressor in gastric cancer? We
used luciferase reporter assay and western blot to
conﬁrm that SP1 is a target of miR-335 in gastric
cancer cells. Sp1 is a sequence-speciﬁc DNA-binding
protein that is an extremely versatile protein involved in
the expression of many different genes (Suske, 1999). It
is overexpressed in a number of human cancers, and its
overexpression contributes to malignant transformation
by regulating the expression of a number of genes
participating in multiple aspects of tumorigenesis, such
as angiogenesis, cell growth and resistance to apoptosis
(Lou et al., 2005; Wang et al., 2005; Kanai et al., 2006).
Recent studies have shown that Sp1 has important roles
in gastric cancer development and progression. Its high
expression level is correlated with advanced disease
stage, lymph-node metastasis and poor survival rates
(Wang et al., 2003; Yao et al., 2004). Knockdown of SP1
gene expression signiﬁcantly inhibited the invasion and
metastasis of SGC-7901 cells in vitro. These results
demonstrate that miR-335 may act as a metastasis
suppressor in gastric cancer by targeting SP1.
Bcl-w is an anti-apoptotic member of the Bcl-2
protein family. The mechanism by which Bcl-w sup-
presses apoptosis is that Bcl-w interacts directly with
pro-apoptotic members to block their apoptotic activ-
ities (Gross et al., 1999; Antonsson, 2001; Uren et al.,
2007; Bae et al., 2009). Recent evidence suggests that the
expression of Bcl-w is signiﬁcantly associated with
inﬁltrative morphotypes (Lee et al., 2003). It can
activate the PI3K/Akt pathway, which is involved in
tumor cell invasion, by elevating PI3K activity and Akt
phosphorylation. Inhibiting either PI3K or Akt both
abolish Bcl-w-induced Sp1 activation. These suggest
that overexpression of Bcl-w in gastric cancer cells
results in an increase in their migratory and invasive
potentials by activating the PI3K-Akt-Sp1 pathway (Lee
et al., 2003; Bae et al., 2006, 2009). We have conﬁrmed
Figure 4 SP1 and Bcl-w are potential targets of miR-335 in gastric cancer cells. (a) Analysis of luciferase activity of SP1 and SP1-
MUT with miR-335 mimics or NCs in SGC-7901 cells. * Refers to statistical signiﬁcance between groups (Po0.05). (b) Analysis of
luciferase activity of Bcl-w and Bcl-w-MUT with miR-335 mimics or NCs in SGC-7901 cells. * Refers to statistical signiﬁcance between
groups (Po0.05). (c) mRNA expression analysis for SP1 in parental and transfected SGC-7901 cells by real-time qRT–PCR. No
signiﬁcant difference in the level of the endogenous SP1 mRNA was found in transfected and parental SGC-7901 cells normalized to an
endogenous reference GAPDH mRNA. (d) mRNA expression analysis for Bcl-w in parental and transfected SGC-7901 cells by real-
time qRT–PCR. No signiﬁcant difference in the level of endogenous Bcl-w mRNA was found in transfected and parental SGC-7901
cells normalized to an endogenous reference GAPDH mRNA. (e) Protein expression analysis for SP1 and Bcl-w in miR-335-
transfected, NC-transfected and parental SGC-7901 cells by western blot. A clear reduction in the level of the endogenous SP1 and
Bcl-w proteins was demonstrated in miR-335-transfected SGC-7901 cells than in NC-transfected SGC-7901 cells normalized to
an endogenous reference b-actin protein. (f) Protein expression analysis for SP1 and Bcl-w in anti-miR-335-transfected, anti-NC-
transfected and parental SGC-7901 cells by western blot. The level of the endogenous SP1 and Bcl-w proteins was increased in
anti-miR-335-transfected SGC-7901 cells than in anti-NC-transfected SGC-7901 cells normalized to an endogenous reference
b-actin protein.
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Oncogenethat Bcl-w is a target of miR-335 in gastric cancer cells;
knockdown of Bcl-w gene expression signiﬁcantly
inhibited the invasion and metastasis of SGC-7901 cells
in vitro. These observations demonstrate that miR-335
not only targets SP1 directly but also targets SP1
indirectly through a Bcl-w-induced signaling pathway
that sequentially involves PI3K, Akt and Sp1. Bcl-w
inducing matrix metalloproteinase-2 expression through
the Bcl-w-induced PI3K-Akt-Sp1 pathway has an
important role in tumor invasion and angiogenesis
(Bae et al., 2006). However, SP1 can regulate not only
matrix metalloproteinase-2 but also a number of other
genes that are important to gastric cancer development
and progression (Qin et al., 1999; Yu et al., 2002; Lou
et al., 2005; Wang et al., 2005; Kanai et al., 2006; Kuo
et al., 2006). Maybe Bcl-w could regulate the expression
of a number of genes by inducing SP1 expression
through the PI3K-Akt-Sp1 pathway. Our ﬁndings also
suggest that miRNA target genes may increase in the
roles that they have by interacting with each other.
Although SP1 and Bcl-w are negatively regulated
directly by miR-335 in gastric cancer cells, miR-335 has
no effect on the SP1 and Bcl-w mRNA levels detected by
qRT–PCR. These results highlight that miR-335 nega-
tively regulates SP1 and Bcl-w expression at the
translational level in gastric cancer.
In conclusion, our study showed that miR-335 is
dramatically downregulated in gastric cancer cell lines
and that the low expression of miR-335 is signiﬁcantly
associated with lymph-node metastasis, poor pT stage,
poor pN stage and invasion into lymphatic vessels.
Moreover, overexpression of miR-335 has the effect of
suppressing gastric cancer cell invasion and metastasis.
miR-335 may act as an important metastasis suppressor
in gastric cancer.
Materials and methods
Tissue samples
Samples of human gastric cancer tissues and paired-adjacent
non-tumor gastric tissues that were farther than 5cm from the
tumors were obtained from 70 patients who underwent radical
resection at the First Hospital of China Medical University.
The median age of patients (57 men and 13 women) was 60
years (range, 26–80 years). Fresh samples were snap frozen in
liquid nitrogen immediately after resection and stored at
 801C. All samples were obtained with patients’ informed
consent and were histologically conﬁrmed by staining with
hematoxylin–eosin. The histological grade of cancers was
assessed according to criteria set by the World Health
Organization. The tumor–node–metastasis stage was per-
formed using standard criteria of the seventh tumor–node–
metastasis staging system.
Cell lines and cell culture
Human gastric cancer cell lines SGC-7901, MGC-803, BGC-
823, AGS and one normal gastric epithelial cell line GES-1 (as
control) were purchased from the Institute of Biochemistry
and Cell Biology at the Chinese Academy of Sciences
(Shanghai, China). SGC-7901, MGC-803 and BGC-823 were
propagated in RPMI 1640 medium (Invitrogen, Carlsbad, CA,
USA), AGS was propagated in F-12K medium (Invitrogen)
and GES-1 was propagated in Dulbecco’s modiﬁed Eagle’s
medium (Invitrogen). All the media were supplemented with
10% fetal bovine serum. Cell lines were cultured at 371Ci na
humidiﬁed incubator of 5% CO2.
RNA extraction and real-time qRT–PCR
Total RNA, inclusive of the small RNA fraction, was
extracted using the mir-Vana miRNA Isolation Kit (Ambion,
Austin, TX, USA) according to the manufacturer’s instruc-
tions. The concentration and purity of RNA were controlled
by ultraviolet spectrophotometry (A260/A280 >1.9) using a
Nano-Photometer ultraviolet/Vis spectrophotometer (Implen,
Schatzbogen, Germany). The 30-termini of RNA were poly-
adenylated by Escherichia coli poly(A) polymerase (E-PAP) at
371C for 30min using the Poly(A) Tailing Kit (Ambion)
following the manufacturer’s instructions. Subsequently, RNA
was extracted with phenol–chloroform and precipitated with
ethanol.
Real-time qRT–PCR was used to conﬁrm the expression
level of mRNAs. Reverse transcription was performed using a
superscript III ﬁrst-strand synthesis system for a RT–PCR kit
(Invitrogen), and real-time qRT–PCR was performed on a
Rotor-gene 2000 Real-time Cycler detection system (Corbett
Research, Sydney, Australia) supplied with analytical soft-
ware, using an Express SYBR greener qPCR supermix
Universal Kit (Invitrogen) according to the manufacturer’s
instructions. The PCR reaction for ampliﬁcation of miR-335
was conducted at 951C for 20s, followed by 45 cycles of 951C
for 5s and 531C for 20s. U6 mRNA levels, as an endogenous
reference, were used for normalization. The PCR reaction for
ampliﬁcation of SP1 and Bcl-w was conducted at 951Co r2 0s ,
followed by 45 cycles of 951C for 5s and 601C for 20s.
Glyceraldehyde 3-phosphate dehydrogenase mRNA levels
were used for normalization as an endogenous reference. After
the ﬁnal cycle, a melting curve analysis was conducted within
the range of 55–951C. The expression level of miR-335 in
cancer relative to its non-tumorous control was calculated
using the equation 2
 DDCT in which DCT¼CT 335 CT U6
(Livak and Schmittgen, 2001). The value of the relative
expression ratio o1.0 was considered as low expression in
cancer relative to the non-tumorous control, whereas others
were considered as high expression. Primers for RT–PCR are
given in Table 2 and Supplementary Table S1.
RNA oligoribonucleotides and cell transfection
All RNA oligoribonucleotides and their respective NCs
(Supplementary Table S2) were purchased from Genepharma
(Shanghai, China). The pyrimidine nucleotides in the miR-335
mimics, anti-miR-335 and their respective NCs were substi-
tuted by their 2-O-methyl analogs to improve RNA stability.
The siRNAs were used to lower SP1 and Bcl-w expressions,
respectively. The target SP1 sequence of the siRNA is
50-AATGAGAACAGCAACAACTCC-30 (Bond et al., 2004)
and the target Bcl-w sequence of the siRNA is 50-AAGGGTT
ATGTCTGTGGAGCT-30 (Yao et al., 2005).
SGC-7901, BGC-823 and AGS cells were plated 1 day
before transfection. A ﬁnal concentration of 50nM of RNA
mimics or 200nM of inhibitor or 100nM of siRNA and their
respective NCs were transfected using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
After 24 or 48h, cells were harvested for further experiments.
Cell invasion assay
We used a transwell cell migration and Matrigel invasion assay
to estimate the invasion ability of parental and transfected
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Serum-free RPMI1640 or F-12K medium was mixed with
Matrigel (1:10; BD Biosciences, Bedford, MA, USA). The
bottom of the culture inserts (8-mm pores) in 24-well tissue
culture plates (Transwell, Corning, Corning, NY, USA) was
coated with 50ml of the mixture, and the Matrigel was allowed
to solidify at 371C for 4h. After solidiﬁcation, 5 10
4 cells
were harvested by trypsinization, washed with serum-free
medium to 25 10
4/ml and placed in the upper chamber. The
lower chamber contained 10% fetal bovine serum for use as a
chemoattractant. After 24h of incubation at 371C with 5%
CO2, the number of cells that had migrated to the basal side of
the membrane was quantiﬁed by counting 16 independent
symmetrical visual ﬁelds under the microscope, and cell
morphology was observed by staining with hematoxylin–eosin.
Tumor metastasis formation assay in vivo
We used the nude mice xenograft model to estimate the
metastatic ability of the parental and transfected SGC-7901
in vivo. Female BALB/c mice (4–5 weeks) were purchased from
the Vital River Laboratory Animal Technology Co. Ltd.
(Beijing, China) and housed in the animal care facilities of the
China Medical University under speciﬁc pathogen-free condi-
tions. After 1 week, 5 10
5 viable cells were resuspended in
0.1ml phosphate-buffered saline and injected into the lateral
tail vein. Five weeks after injection, mice were killed and the
lungs were extracted and ﬁxed in 4% paraformaldehyde in
phosphate-buffered saline. Parafﬁn embedding, sectioning and
staining with hematoxylin–eosin of the lungs were performed
at the First Afﬁliated Hospital of the China Medical
University. Visible lung metastases were measured and
counted using a microscope. All experimental procedures
involving animals were in accordance with the Guide for the
Care and Use of Laboratory Animals (NIH publication no.
80-23, revised 1996) and were performed according to the
institutional ethical guidelines for animal experiment.
MTT proliferation assay
An MTT assay was used to estimate the proliferation ability of
the parental and transfected SGC-7901 cell line. In all, 8 10
3
cells were seeded into 96-well culture plates for 24, 48, 72 and
96h. Cells were then incubated with 20ml of MTT (5mg/ml)
for 4h at 371C. After removing the culture supernatant, 150ml
of dimethyl sulfoxide was added to solubilize the crystals for
20min at room temperature. Absorbance was measured at a
wavelength of 495nM using a spectrophotometer (Multiskan
MK3; Thermo, Shimadzu, Japan).
Bioinformatics analyses
For miRNA target gene prediction, we used TargetScan
Release 5.1 online software (http://www.targetscan.org/).
Among all the genes that were compiled, we determined which
genes may contribute to gastric cancer metastasis.
Vector construction and luciferase reporter assay
For luciferase reporter experiments, 30-UTR segments contain-
ing the miR-335-binding sites of SP1 and Bcl-w were ampliﬁed
by PCR from human genomic DNA and inserted into the
pGL3-control vector (Promega, Madison, WI, USA) using the
XbaI site immediately downstream from the stop codon of
luciferase. DNA segments with scrambled target sites (SP1-
MUT and Bcl-w-MUT) designed to interfere with seed
sequence recognition were also cloned to serve as control for
speciﬁcity. Primers and DNA segments used for vector
construction are indicated in Supplementary Table S3.
SGC-7901 cells were transfected in 24-well plates using
Lipofectamine 2000 according to the manufacturer’s instruc-
tions with 0.8mg of the ﬁreﬂy luciferase report vector and
0.08mg of the control vector containing Renilla luciferase,
pRL-TK (Promega). For each well, 20pM hsa-mir-335 or a NC
was used. Fireﬂy and Renilla luciferase activities were
measured consecutively using a dual-luciferase reporter assay
(Promega) 24h after transfection on a Centro LB 960
(Berthold, Bad Wildbad, Germany).
Protein extraction and western blot
Total protein was extracted from parental and transfected SGC-
7901 cells using a Total Protein Extraction Kit (KeyGen,
Nanjing, China) according to the manufacturer’s instructions.
Measurement of protein concentration was done using a BCA
Protein Assay Kit (KeyGen), and 60mg of each sample was
separated by 12% SDS–PAGE and electrophoretically trans-
ferred to polyvinylidene diﬂuoride membranes (Millipore, Bill-
erica, MA, USA). Nonspeciﬁc binding sites were blocked by
incubating with 5% non-fat dry milk in Tris-buffered saline–
0.5% Tween-20 at room temperature for 1h and incubated at
41C overnight with antibodies directed against SP1, Bcl-w (1:200;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) and b-actin
(1:5000; Sigma, St Louis, MO, USA). The antigen–antibody
complexes were visualized using horseradish peroxidase-conju-
gated secondary antibody and an ECL Kit (Pierce, Rockford, IL,
USA). Quantiﬁcation of protein was carried out using FluorCh-
em 2.01 (Alpha Innotech, San Leandro, CA, USA). SP1 and Bcl-
w protein levels in transfected SGC-7901 cells were presented as
fold change normalized to an endogenous reference (b-actin
protein) and relative to parental SGC-7901 cells. Therefore, a
fold change of o1.0 was considered as low expression.
Statistical analysis
Correlations between miRNA expression and clinicopatholo-
gical features were analyzed by non-parametric tests: Mann–
Whitney U-test between two groups and Kruskal–Wallis test
Table 2 Real-time qRT–PCR primers for ampliﬁcation of expression of miR-335
Primer sequence (50-30)
RT-primer-1 GCTGTCAACGATACGCTACGTAACGGCATGACAGTGTTTTTTTTTTTTTTTTTTTTTTTTA
RT-primer-2 GCTGTCAACGATACGCTACGTAACGGCATGACAGTGTTTTTTTTTTTTTTTTTTTTTTTTG
RT-primer-3 GCTGTCAACGATACGCTACGTAACGGCATGACAGTGTTTTTTTTTTTTTTTTTTTTTTTTC
miR-335-F
a TCAAGAGCAATAACGAAAAATGT
miR-335-R
b GCTGTCAACGATACGCTACGT
U6 RNA-F
a CGCTTCGGCAGCACATATAC
U6 RNA-R
b TTCACGAATTTGCGTGTCAT
Abbreviation: qRT–PCR, quantitative reverse-transcriptase PCR.
aForward primer.
bReverse primer.
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Oncogenefor three or more groups. All the other results are presented as
mean±s.d. from at least three separate experiments and were
submitted to analysis using Student’s t-test. All statistical
analyses were preformed using SPSS 16.0 computer software
(SPSS Inc., Chicago, IL, USA). P-values o0.05 were
considered as statistically signiﬁcant.
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